infectious vaccines partnering terms and agreements

10

Click here to load reader

Upload: market-research-reports-inc

Post on 07-Jul-2015

96 views

Category:

Healthcare


0 download

DESCRIPTION

Market Research Reports, Inc. has announced the addition of “Infectious Vaccines Partnering Terms and Agreements” research report to their offering. See more at- http://mrr.cm/ZM9

TRANSCRIPT

Page 1: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

Page 2: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Introduction to Report

Launch Date: June 1, 2014

Number of Pages: 620

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 1,995

Price For Site License: USD 5,995

Price For Global User License: USD 9,995

Delivery Time: Within 24 Hours (During Working Days)

Page 3: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

About the Report

The Infectious Vaccines Partnering Terms and Agreementsreport provides a detailed understanding and analysis ofhow and why companies enter infectious vaccinespartnering deals. The majority of deals are developmentstage whereby the licensee obtains a right or an optionright to license the licensors vaccine technology.

These deals tend to be multicomponent, starting withcollaborative R&D, and commercialization of outcomes.The report also includes adjuvant deals and alliances.

Page 4: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Research Findings

Chapter 1 provides an introduction to the report, whilst chapter2 provides an overview of the trends in infectious vaccinesdealmaking since 2009, including details of average headline,upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading infectious vaccinesdeals since 2009. Deals are listed by headline value. Where thedeal has an agreement contract published at the SEC a linkprovides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies for which deals are available, with a briefsummary followed by a comprehensive listing of infectiousvaccines deals, as well as contract documents available in thepublic domain.

Page 5: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Research Findings Continues..

Chapter 5 provides a comprehensive listing of the big biotechcompanies for which deals are available, with a brief summaryfollowed by a comprehensive listing of infectious vaccines deals,as well as contract documents available in the public domain.

Chapter 6 provides a comprehensive and detailed review ofinfectious vaccines partnering deals signed and announced sinceJanuary 2009. The chapter is organized by company A-Z, stage ofdevelopment at signing, deal type (collaborative R&D, co-promotion, licensing etc), specific therapy focus and specifictechnology type focus.

Page 6: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Infectious Vaccines Partnering Agreements includes:

Trends in infectious vaccines dealmaking in the biopharmaindustry since 2009

Analysis of infectious vaccines deal structure

Access to headline, upfront, milestone and royalty data

Access to over 500 infectious vaccines deal records

The leading infectious vaccines deals by value since 2009

Includes adjuvant deals and alliances since 2009

Page 7: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Benefits

In-depth understanding of infectious vaccines deal trends since2009

Access infectious vaccines deal headline, upfront, milestoneand royalty data

Research hundreds of actual contracts between infectiousvaccines partner companies

Comprehensive access to over 500 links to actual infectiousvaccines deals entered into by the world’s biopharma companies

Indepth review of infectious vaccines deals entered into by theleading fifty bigpharma companies

Benchmark the key deal terms companies have agreed inprevious deals

Identify key terms under which companies partner infectiousvaccines opportunities

Uncover companies actively partnering infectious vaccinesopportunities

Page 8: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Report Coverage

1. Executive Summary

2. Introduction

3. Trends in infectious vaccines dealmaking

4. Leading infectious vaccines deals

5. Big pharma infectious vaccines deals

6. Big biotech infectious vaccines deals

7. Infectious Vaccines dealmaking directory

8. Partnering resource center

9. Appendices

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 9: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

Custom Research:

Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let

us know your specific research requirements. Our goal

is to cater to your requirements be it for a custom

market research project, syndicated research report on

a specific market or industry sector, newsletter creation,

case study development or anything else related to

marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

Page 10: Infectious Vaccines Partnering Terms and Agreements

www.MarketResearchReports.com

How To Buy This Report?

Visit following URL to see Table of Content and

purchase this publication:

http://mrr.cm/ZM9

About Market Research Reports, Inc.

Market Research Reports provides a customized set

of reports from reputed Publishers, built on the

intelligence available within organizations and

leverages on our motto of “Intelligence Redefined”.

Contact : Amitava Sen

Email : [email protected]

Phone: +1 302-703-7787 (USA) +91-8762746600 (India)